Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2020 2
2021 5
2022 6
2023 10
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Updates for Colon Cancer Care in 2022.
Fabregas JC, Ramnaraign B, George TJ. Fabregas JC, et al. Among authors: ramnaraign b. Clin Colorectal Cancer. 2022 Sep;21(3):198-203. doi: 10.1016/j.clcc.2022.05.006. Epub 2022 Jun 3. Clin Colorectal Cancer. 2022. PMID: 35729033 Review.
Immunotherapy Management in Special Cancer Patient Populations.
Ramnaraign BH, Chatzkel JA, Al-Mansour ZA, Rogers S, Jones D, DeRemer D, George TJ. Ramnaraign BH, et al. JCO Oncol Pract. 2021 May;17(5):240-245. doi: 10.1200/OP.20.00996. Epub 2021 Mar 12. JCO Oncol Pract. 2021. PMID: 33710933 Review.
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.
George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. George TJ, et al. Among authors: ramnaraign bh. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626160 Free PMC article. Clinical Trial.
Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic.
Cicali EJ, Eddy E, Gong Y, Elchynski AL, Pena Del Aguila K, Basha T, Daily KC, Dickson L, Fischer S, Hastings-Monari E, Jones D Jr, Ramnaraign BH, DeRemer DL, George TJ, Cooper-DeHoff RM. Cicali EJ, et al. Among authors: ramnaraign bh. Clin Transl Sci. 2024 Jul;17(7):e13890. doi: 10.1111/cts.13890. Clin Transl Sci. 2024. PMID: 39046302 Free PMC article. Clinical Trial.
Reply to A.R. Khaki et al.
Ramnaraign BH. Ramnaraign BH. JCO Oncol Pract. 2021 Sep;17(9):584-586. doi: 10.1200/OP.21.00484. Epub 2021 Jul 23. JCO Oncol Pract. 2021. PMID: 34297604 No abstract available.
Tivozanib for the treatment of advanced renal cell carcinoma.
Chatzkel J, Ramnaraign B, Sonpavde G. Chatzkel J, et al. Among authors: ramnaraign b. Expert Opin Pharmacother. 2022 Jul;23(10):1135-1142. doi: 10.1080/14656566.2022.2102419. Epub 2022 Jul 25. Expert Opin Pharmacother. 2022. PMID: 35848061
29 results